Doménica Torres
N-SIDE and Merck Healthcare KGaA explain how a collaborative approach combining optimization and processes efficiently reduces sourcing costs and drug waste in the clinical trial supply chain. Read the article in Arena International’s Virtual Events: Review and Summary Handbook.
Rita Meirinhos, Life Sciences Senior Consultant at N-SIDE and Fan Feng, Associate Director Clinical Supply Chain at Merck Healthcare KGaA, co-presented at Arena’s Clinical Trial Supply Europe 2021 and Clinical Trial Supply USA 2021. Their presentations led to the collaborative publication “How to efficiently reduce sourcing costs and drug waste” in the organization’s latest handbook: Virtual Events: Review and Summary, which compiles articles written by different clinical trial supply stakeholders, focusing on the most successful topics and discussions that took place during these virtual clinical trial events.
N-SIDE is specially proud of the collaboration with Merck Healthcare KGaA to put together two successful showcases with approximately 130 attendees in total, as well as of the joint effort to publish this article. Read it now to understand where the industry stands with regards to drug waste and the impact it has globally, in addition to:
-
Identify the drivers of drug waste in your clinical trial and the solutions to avoid it;
-
Discover a case study outlining how N-SIDE and Merck Healthcare KGaA reduced the comparator budgets and drug waste by optimizing the trial design; and
-
Learn how to make this feasible in your organization through new processes and collaboration.
You can find the article, as well as the entire Arena handbook clicking on the link below:
